Microplastics raise toxicity of organic pollutants by 10x
Study suggests microplastics are a magnet for environmental pollutants, ferrying them through our digestive tract and causing severe health damage.
Study suggests microplastics are a magnet for environmental pollutants, ferrying them through our digestive tract and causing severe health damage.
New Phase nanotech company aims to transform end-stage cancer from a likely death sentence to a chronic illness.
Pi-Cardia’s Leaflex device delays the need for a prosthetic valve, while its ShortCut device makes valve replacement safer.
Through UNICEF, TytoCare sends 50 devices to hospitals in isolated villages so that parents and children won’t have to travel on dangerous roads.
For the first time, researchers identified brain wounds in army veterans with PTSD and relieved their symptoms using hyperbaric oxygen therapy.
As Omicron wave wanes, Israeli government decides to admit foreign citizens of all ages, regardless of vaccination status, subject to virus testing.
An electronic nose that sniffs cancer, a wearable lab that detects poisons in buildings, self-healing electronic devices, Hossam Haick is constantly inventing devices designed to change our lives.
Sheba Medical Center set to enroll first study outside of US to test new formulation against Omicron and other emerging variants.
Women reportedly suffer more from arm pain, headaches and weakness following the Pfizer-BioNTech vaccine, but scientists unsure of mechanism involved.
Researchers believe low-arousal states expose failures in a mechanism that regulates stability of brain activity in the early, pre-symptomatic stage of Alzheimer’s disease.
Innovations in the field of sustainability and why there is a push in the food market for alternatives.
Study also finds previously infected obese patients, contrary to expectations, had a higher and more sustained immune response.
Israeli oncologist and neuroscientist collaborate on multisensory gadgets to enhance hope and wellbeing for cancer patients, families and staff.
First-ever spinal cord implant to treat paralysis without risk of rejection is successfully tested on mice; human trials expected by end of 2024.
Israeli study finds stress and anxiety at hospitals worse than expected, as ancillary staff also affected and smoking increases.